Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

Nature Immunology

Volumn 4, Issue 10, 2003, Pages 1009-1015

  Le Bon, Agnes ^a   Etchart, Nathalie ^a,d   Rossmann, Cornelia ^b   Ashton, Miranda ^a   Hou, Sam ^a   Gewert, Dirk ^c   Borrow, Persephone ^a   Tough, David F ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^b Acambis   (United States)

^c BioLauncher   (United Kingdom)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CROSS REACTION; DENDRITIC CELL; HOST RESISTANCE; INFECTION RESISTANCE; INTERFERON INDUCTION; LIGAND BINDING; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD40; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; INTERFERON TYPE I; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0142092614     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni978     Document Type: Article

References (50)

1. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. 1, 362-368 (1999).
2. Heath, W.R. & Carbone, F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19, 47-64 (2001).
3. Kurts, C., Cannarile, M., Klebba, I. & Brocker, T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166, 1439-1442 (2001).
4. + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099-1104 (2002).
5. + dendritic cells abrogates priming of CD8 T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002).
6. Bevan, M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288 (1976).
7. Gordon, R.D., Mathieson, B.J., Samelson, L.E., Boyse, E.A. & Simpson, E. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-Y antigen. J. Exp. Med. 144, 810-820 (1976).
8. Gooding, L.R. & Edwards, C.B. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic lymphocytes. J. Immunol. 124, 1258-1262 (1980).
9. Carbone, F.R. & Bevan, M.J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171, 377-387 (1990).
10. + T cells. J. Exp. Med. 186, 239-245 (1997).
11. + T cell help. J. Exp. Med. 186, 65-70 (1997).
12. Bennet, S.R.M. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478-480 (1998).
13. Schoenberger, S.P., Toes, R.E.M., van der Voort, E.I.H., Offringa, R. & Melief, C.J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483 (1998).
14. + T-helper and a T-killer cell. Nature 393, 474-478 (1998).
15. Liu, K. et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097 (2002).
16. Mazzaccaro, R.J. et al. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 93, 11786-11791 (1996).
17. Simmons, C.P. et al. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. J. Immunol. 163, 6502-6510 (1999).
18. Cho, H.J. et al. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat. Biotechnol. 18, 509-514 (2000).
19. + T cells. J. Immunol. 167, 5603-5609 (2001).
20. Sigal, L.J., Crotty, S., Andino, R. & Rock, K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77-80. (1999).
21. Mueller, S.N., Jones, C.M., Smith, C.M., Heath, W.R. & Carbone, F.R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195, 651-656 (2002).
22. Goodbourn, S., Didcock, L. & Randall, R.E. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 81, 2341-2364 (2000).
23. Siegal, F.P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999).
24. Luft, T. et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947-1953 (1998).
25. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255 (1999).
26. Ito, T. et al. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166, 2961-2969 (2001).
27. Le Bon, A. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461-470 (2001).
28. Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263-3271 (2002).
29. von Hoegen, P., Zawatzky, R. & Schirrmacher, V. Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-α/β. Cell. Immunol. 126, 80-90. (1990).
30. + T cell mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-γ-producing TS/A cells. J. Immunol. 153, 4604-4615 (1994).
31. Tough, D.F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950 (1996).
32. Van Uden, J.H., Tran, C.H., Carson, D.A. & Raz, E. Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur. J. Immunol. 31, 3281-3290 (2001).
33. + T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 168, 4907-4913 (2002).
34. Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
35. Merigan, T.C., Oldstone, M.B. & Welsh, R.M. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 268, 67-68 (1977).
36. Korngold, R., Blank, K.J. & Murasko, D.M. Effect of interferon on thoracic duct lymphocyte output: Induction with either poly I:poly C or vaccinia virus. J. Immunol. 130, 2236-2240 (1983).
37. Moore, M.W., Carbone, F.R. & Bevan, M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777-785 (1988).
38. Lefrancois, L., Altman, J.D., Williams, K. & Olson, S. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J. Immunol. 164, 725-732 (2000).
39. + cytotoxic T lymphocytes. J. Exp. Med. 191, 541-550 (2000).
40. Zhan, Y., Corbett, A.J., Brady, J.L., Sutherland, R.M. & Lew, A.M. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation. J. Immunol. 165, 3612-3619 (2000).
41. + T cell memory. Science 297, 2060-2063 (2002).
42. + T lymphocytes. Nature 421, 852-856 (2003).
43. Sun, J.C. & Bevan, M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300, 339-342 (2003).
44. Shedlock, D.J. & Shen, H. Requirement for CD4 T cell help in generating functional CDB T cell memory. Science 300, 337-339 (2003).
45. Josien, R. et al. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 191, 495-502 (2000).
46. Bevan, M.J. Immunology. Stimulating killer cells. Nature 342, 478-479 (1989).
47. Jamaluddin, M. et al. IFN-β mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L248-L257 (2001).
48. Dutko, F.J. & Oldstone, M.B. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64, 1689-1698 (1983).
49. Chakrabarti, S., Brechling, K. & Moss, B. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5, 3403-3409 (1985).
50. Restifo, N.P. et al. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154, 4414-4422 (1995).